BioCryst Pharmaceuticals
Aug 1, 2025
C5 Drug Candidate Efficacy & Toxicity
Developed AP ELISA and ZMAC30 assays to interrogate drug candidate performance and safety in tissue culture. Acquired practical skills spanning both assay development and the drug discovery process in an industry setting.
Aug 1, 2025
BioCryst Pharmaceuticals
Aug 1, 2025